The tipping point? Half of people now survive cancer diagnosis

New research shows, for the first time, half of patients live for at least 10 years after diagnosis

Health Reporter

Half of all people diagnosed with cancer in England and Wales today will survive the disease, Britain’s leading research charity has said, in a landmark announcement which experts have hailed as a “tipping point” in the global fight against cancer.

Using the largest and most up-to-date set of statistics on cancer treatment and survival available anywhere in the world, Cancer Research UK have been able to estimate that 50 per cent of patients who were diagnosed in 2010-11 will survive for 10 years – effectively meaning that they have been cured.who

Announcing their findings, which are derived from an analysis of survival trends involving more than seven million cancer patients diagnosed between 1971 and 2011 in England and Wales, Cancer Research UK said that by the 2030s, it was realistic to hope that as many as three in every four cancer patients would survive 10 years after diagnosis.

In the 1970s, the 10-year survival rate was as low as one in four In the 1970s, the 10-year survival rate was as low as one in four

In the 1970s, the 10-year survival rate was as low as one in four, but a combination of improved therapies and drugs, earlier diagnosis and a reduction in the smoking rate have contributed to huge improvements in outcomes, with some types of cancer now nearing 100 per cent survival.

Dr Harpal Kumar, the charity’s chief executive, said that the past 20 years had seen an “explosion” in our understanding of the disease.

“We know more about cancer than we ever have before…the knowledge that we have gained in the past 20 years puts us in a fantastic position, not just to continue the progress we’ve made, but to accelerate it…” he said. “In 20 years’ time, we want three quarters of the people who hear those words: ‘you’ve got cancer’, to also hear the words: ‘but don’t worry you’ll be fine’. We firmly believe that’s achievable.”

Survival rates for nearly all cancers are improving every year. In the past 40 years, the 10-year survival rate for breast cancer has increased from 40 per cent to 78 per cent; for malignant melanoma from 46 to 89 per cent; and for testicular cancer from 69 to 98 per cent, according to research carried out for the charity by a team working under Professor Michel Coleman at the London School of Hygiene and Tropical Medicine.

However, the prospects for other types of cancer – in particular pancreatic and lung cancer – remain poor around the world. Survival rates in England and Wales, along with the rest of the UK, lag behind comparable countries in western Europe – largely because of delays in diagnosis of hard-to-spot cancers.

Dr Kumar said that, while the 50 per cent statistic was a major milestone, there was “a huge amount” of work still to do.

“We don’t want to celebrate the fact that only 50 per cent of patients are surviving their cancer,” he said. “In the UK that means around 160,000 people a year still don’t survive for 10 years or more, and across the world around eight million people.”

Charity runner Tony Phoenix-Morrison at the London Marathon this year. Cancer Research UK aims to boost its annual £350m spending on cures by 50 per cent over the next five to 10 years Charity runner Tony Phoenix-Morrison at the London Marathon this year. Cancer Research UK aims to boost its annual £350m spending on cures by 50 per cent over the next five to 10 years (PA)

The charity is seeking to increase its £350 million annual spend on cancer research by 50 per cent over the next five to 10 years, Dr Kumar said. Research will particularly target new means of diagnosing and treating those cancers with stubbornly low survival rates. Pancreatic cancer has a 10-year survival rate of just one per cent, and is the only cancer for which death rates are still rising in Europe for both men and women.

And despite dramatic falls in the number of smokers since the 1970s, lung cancer death rates are still rising among women and for all patients 10-year survival is only five per cent. 

But prospects for ever-improving survival rates, even in the most hard-to-treat cancers, were given a major boost earlier this month as Cancer Research UK announced a ground-breaking drug trial which aims to identify “personalised” cancer drugs for lung cancers. The trial, the first of its kind, builds on the “genetic revolution” in cancer science, and a new understanding of the extent to which the genetic makeup of different people’s cancer tumours can vary, requiring a broader range of more targeted drug treatments.

“As little as 20 years ago people were talking about a single magic bullet for cancer,” Dr Kumar said. “This notion that there would be one type of treatment that would be beneficial across all types of cancer [has been] put to bed, that isn’t ever going to be the case.”

Professor Coleman said that 10-year survival in the vast majority of cases meant that the disease had been beaten.

“As a whole the patients who survive that long no longer have any different chances of surviving than the rest of the population,” he said.

“The idea of cancer as a death sentence is gradually evaporating in this country, thank goodness,” he added. “It is still considered a death sentence in many countries around the world, to the extent that people given a diagnosis will not seek treatment because they accept with fatalism that they are going to die… that is the kind of perception, the kind of myth… that data like this can counter.”

Late diagnosis was among the key reasons for poor survival rates in some cancers, he said, particularly those for which symptoms are non-specific, such as persistent cough in the case of lung cancer, a sore throat for oesophageal cancer, or a headache for brain tumours.

Delays in patients visiting their GP, in GPs diagnosing cancers and in referrals to treatment have all been identified as causes for the UK’s comparatively poor performance on cancer. However Professor Coleman said it was wrong to solely blame GPs who he said were seeing between six and eight cases of cancer out of thousands of patient contacts every year. 

Life and Style
ebookNow available in paperback
ebooks
ebookPart of The Independent’s new eBook series The Great Composers
Arts and Entertainment
Buttoned up: Ryan Reynolds with Helen Mirren in ‘Woman in Gold’
filmFor every box-office smash in his Hollywood career, there's always been a misconceived let-down. Now he says it's time for a reboot
News
people
News
Actress Julianne Moore wins the Best Actress in a Leading Role Award for 'Still Alice' during the 87th Annual Academy Awards in Hollywood, California
people
Sport
Ross Barkley
footballPaul Scholes says it's time for the Everton playmaker to step up and seize the England No 10 shirt
News
'We will fix it': mice in the 1970s children’s programme Bagpuss
science
Life and Style
2 Karl Lagerfeld and Choupette
fashion
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Recruitment Genius: Customer Service Executive

    £18000 - £22000 per annum: Recruitment Genius: This is an exciting opportunity...

    Recruitment Genius: Retail Buyer / Ecommerce Buyer

    £30000 - £35000 per annum: Recruitment Genius: Working closely with the market...

    Recruitment Genius: Sales Executive - CAD Software Solutions Sales

    £20000 - £50000 per annum: Recruitment Genius: A reputable company, famed for ...

    Ashdown Group: Client Accountant Team Manager - Reading

    Negotiable: Ashdown Group: The Ashdown Group has been engaged by a highly resp...

    Day In a Page

    War with Isis: Iraq declares victory in the battle for Tikrit - but militants make make ominous advances in neighbouring Syria's capital

    War with Isis

    Iraq declares victory in the battle for Tikrit - but militants make make ominous advances in neighbouring Syria
    Scientists develop mechanical spring-loaded leg brace to improve walking

    A spring in your step?

    Scientists develop mechanical leg brace to help take a load off
    Peter Ackroyd on Alfred Hitchcock: How London shaped the director's art and obsessions

    Peter Ackroyd on Alfred Hitchcock

    Ackroyd has devoted his literary career to chronicling the capital and its characters. He tells John Walsh why he chose the master of suspense as his latest subject
    Ryan Reynolds interview: The actor is branching out with Nazi art-theft drama Woman in Gold

    Ryan Reynolds branches out in Woman in Gold

    For every box-office smash in Ryan Reynolds' Hollywood career, there's always been a misconceived let-down. It's time for a rethink and a reboot, the actor tells James Mottram
    Why Robin Williams safeguarded himself against a morbid trend in advertising

    Stars safeguard against morbid advertising

    As film-makers and advertisers make increasing posthumous use of celebrities' images, some stars are finding new ways of ensuring that they rest in peace
    The UK horticulture industry is facing a skills crisis - but Great Dixter aims to change all that

    UK horticulture industry facing skills crisis

    Great Dixter manor house in East Sussex is encouraging people to work in the industry by offering three scholarships a year to students, as well as generous placements
    Hack Circus aims to turn the rule-abiding approach of TED talks on its head

    Hack Circus: Technology, art and learning

    Hack Circus aims to turn the rule-abiding approach of TED talks on its head. Rhodri Marsden meets mistress of ceremonies Leila Johnston
    Sevenoaks is split over much-delayed decision on controversial grammar school annexe

    Sevenoaks split over grammar school annexe

    If Weald of Kent Grammar School is given the go-ahead for an annexe in leafy Sevenoaks, it will be the first selective state school to open in 50 years
    10 best compact cameras

    A look through the lens: 10 best compact cameras

    If your smartphone won’t quite cut it, it’s time to invest in a new portable gadget
    Paul Scholes column: Ross Barkley played well against Italy but he must build on that. His time to step up and seize that England No 10 shirt is now

    Paul Scholes column

    Ross Barkley played well against Italy but he must build on that. His time to step up and seize that England No 10 shirt is now
    Why Michael Carrick is still proving an enigma for England

    Why Carrick is still proving an enigma for England

    Manchester United's talented midfielder has played international football for almost 14 years yet, frustratingly, has won only 32 caps, says Sam Wallace
    Tracey Neville: The netball coach who is just as busy as her brothers, Gary and Phil

    Tracey Neville is just as busy as her brothers, Gary and Phil

    The former player on how she is finding time to coach both Manchester Thunder in the Superleague and England in this year's World Cup
    General Election 2015: The masterminds behind the scenes

    The masterminds behind the election

    How do you get your party leader to embrace a message and then stick to it? By employing these people
    Machine Gun America: The amusement park where teenagers go to shoot a huge range of automatic weapons

    Machine Gun America

    The amusement park where teenagers go to shoot a huge range of automatic weapons
    The ethics of pet food: Why are we are so selective in how we show animals our love?

    The ethics of pet food

    Why are we are so selective in how we show animals our love?